Agoracom Blog Home

Posts Tagged ‘medical Marijuana’

« Older Entries
Newer Entries »

Enertopia Announces AGM Results

Posted by AGORACOM-JC at 8:06 AM on Wednesday, July 23rd, 2014

 

Vancouver, BC /July 23 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce all resolutions were approved and adopted at its Annual General Meeting (AGM) held on July 15th.

Re-election of directors was approved with the following results:

Nominee For Withhold Not Voted
Robert McAllister 18,929,105 (99.41%) 113,264 (0.59%) 11,529,448
Donald Findlay 18,963,169 (99.58%) 79,200 (0.42%) 11,529,448
John Thomas 19,000,854 (99.78%) 41,515 (0.22%) 11,529,448
Mathew Chadwick 2,084,772 (10.95%) 16,957,597 (89.05%) 11,529,448

 

-Ratification of MNP LLP our independent registered public accounting firm to hold office until the close of the next annual general meeting and to allow directors to set the remuneration, approved with 30,286,680 votes For (99.07%), 285,136 votes Against (0.93%) and 1 vote Not Voted; and

-Ratification of the change of business to the regulated marijuana industry was passed with 19,029,444 votes For (99.93%), 12,925 votes Against (0.07%), and 11,529,448 Not Voted; and

-Shareholders approved the compensation of our company’s named executive officers (Say-On-Pay), by a vote of 19,008,019 votes For (99.82%), 34,350 votes Against (0.18%), and 11,554,370 Not Voted; and

-Shareholders approved a 3-year frequency (Say-When-On-Pay) of future advisory votes on the compensation of our company’s named executive officers, by the following votes One Year – 1,452,183, Two Years – 74,858 Three Years – 17,490,406, Not Voted – 11,554,370; and

-Ratification of the Company’s 2014 stock option plan was passed with 18,996,969 votes For (99.76%), 45,400 votes Against (0.24%), and 11,529,448 Not Voted.

The Company also notes that 252,000 warrants have been exercised raising $25,200 in net proceeds.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in the USA with symbol ENRT and in Canada with symbol TOP.

To learn more about Enertopia Corp. visit www.enertopia.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces AGM Results

InvestmentPitch Media Attending Next Gen Metal’s GreenRush Financial Conference in Seattle, Washington on September 23, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines

Posted by AGORACOM-JC at 6:32 PM on Tuesday, July 22nd, 2014

Vancouver, British Columbia–(July 22, 2014) – InvestmentPitch Media will be attending the upcoming GreenRush Financial Conference in Seattle, Washington. Following very successful GreenRush Financial Conferences in Vancouver in May, and Toronto in June, arrangements are in place for the next conference which will be held on September 23rd at the Washington State Convention Centre, from 7:00 am to 5:00 pm.

For more details, please watch this video. If this link is not enabled, please visit www.InvestmentPitch.com and enter “GreenRush Conference” in the search box. InvestmentPitch is a media partner for this event, and will be available to film presentations and conduct interviews.


http://www.investmentpitch.com/video/0_wjudlxo5/InvestmentPitch-Media-Invite–GreenRush-Financial-Conference-in-Seattle-Washington–Sept-23-2014

Harry Barr, CEO, stated: “We are pleased with the results of the first two Canadian GreenRush Financial Conferences and look forward to exporting our success and brand to the United States. We would like to thank the 40+ exhibitors, 1200+ attendees and expert speakers from around the world that came together to make this Toronto conference the success that it was. We look forward to hosting our third GreenRush Financial Conference in Seattle, Washington which is the newest state to legalize recreational marijuana. Given the size of the US market, its population when compared to Canada and the fact that marijuana is legal both recreationally and medically in Washington State we anticipate that our third conference will be even bigger and better received than our conferences have been to date.”

The conference will provide a platform for venture capital investment, education and business to business opportunities, with exhibitors having a forum to showcase their products, technologies and services. For further information or to register as an attendee for the Seattle Conference, please visit www.greenrushfinancialconferences.com.

For information about further conferences, which are also being considered for North and South America as well as Europe and the Caribbean, please register on their site.

If you are interested in being a speaker, exhibitor or sponsor for the Seattle Conference please contact the GreenRush Financial Conference team at 604-685-1870 or 1-800-667-1870 or email the following:

Taylor Barr [email protected]
Ray Rich [email protected]

The GreenRush Financial Conferences are 100% owned by Next Gen Metals Inc. (CSE:N). Next Gen focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors, and is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

Next Gen recently announced a non-brokered private placement of up to 3,000,000 units at $0.10 per unit, for gross proceeds of up to $300,000. For more information about Next Gen, please visit www.nextgenmetalsinc.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals,

specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
[email protected] 

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on InvestmentPitch Media Attending Next Gen Metal’s GreenRush Financial Conference in Seattle, Washington on September 23, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines

Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia

Posted by AGORACOM-JC at 10:25 AM on Tuesday, July 22nd, 2014

WHITEFISH, MT / July 22, 2014 / The Marijuana Index(TM) moved slightly higher last week, despite a 7% drop in GW Pharmaceuticals plc (NASDAQ: GWPH) shares. Medbox Inc. (OTC: MDBX), the second largest component of the index, also fell over 5% last week.

Top gainers last week included Nuvilex Inc. (OTC: NVLX), which jumped more than 16.5% after reporting positive results in dogs for its anticancer treatment, Enertopia Corp. (OTC: ENRT), which jumped more than 13% after receiving municipal approval for its MMPR joint venture in Burlington, Ontario, and Novus Acquisition & Development Corp. (OTC: NDEV), which rose more than 12% last week.

Cannabis regulatory initiatives also gained ground last week. In a favorable swing, the U.S. House of Representatives voted to support making it easier for cannabis-related companies to access the commercial banking sector. A new survey also found that U.S. citizens are increasingly embracing both medical and recreational marijuana following the successful rollout of both programs in several states.

What’s New?

– CannLabs Continues to Make Tremendous Strides – CannLabs Inc. (OTC: CANL) recently announced the addition of industry experts to its leadership team, updates to its services to accommodate new Colorado MED testing requirements, and a new ticker symbol.

– West Point Starts Cannabis Breathalyzer Development – West Point Resources Inc. (CNSX: BLO) recently announced that it has selected a prototype development firm to complete the initial version of its Cannabix Marijuana Breathalyzer in partnership with its engineering team.

– A Supreme Opportunity in the Cannabis Space – CannabisFN takes a look at Supreme Pharmaceuticals Inc. (OTC: SPRWF) and its low-risk, high-reward strategy for obtaining licensed producer status from Health Canada under the country’s new MMPR framework introduced this year.

– House Votes to Allow Marijuana-Related Banking – The U.S. House of Representatives voted 236-186 in support of making it easier for cannabis-related businesses to work with commercial banks, a problem that has caused some marijuana businesses to become criminal targets.

– Cannabis Therapy’s Multi-Pronged Approach – CannabisFN takes a look at Cannabis Therapy Inc.’s (OTC: CTCO) unique business strategy, existing hemp cultivation, and why their laboratory research could be a significant catalyst for the stock over the coming quarters.

– Capitalize on the Green Rush with DigiPath – CannabisFN takes a look at DigiPath Inc. (OTC: DIGP) and its unique and synergistic plans within the cannabis industry focusing on laboratory testing, training/education, and cannabis-related media ventures.

What to Watch This Week

The cannabis sector continues to move higher, as it recovers from its lows made earlier this year. In Canada, investors are still waiting for MMPR licensing decisions to be made for several companies, while keeping an eye on the injunction that’s keeping the country’s MMAR program alive for now. In the U.S., regulators appear to be increasingly supportive of cannabis, as state-wide experiments continue to be positive in terms of both public safety and tax revenue from cannabis.

About CannabisFN

CannabisFN.com is a dedicated financial network covering new, emerging and established companies operating in the burgeoning multi-billion dollar medical marijuana (“MMJ”) and cannabis industries. CannabisFN’s coverage is syndicated on the leading industry specific and mainstream financial websites and social media. To learn more and request a media kit, visit http://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , ,
Posted in Enertopia Corp. | Comments Off on Cannabis Stocks Edge Higher Last Week Led by Nuvilex & Entertopia

Toronto opens first referral-only medical marijuana clinic

Posted by AGORACOM-JC at 11:26 AM on Monday, July 21st, 2014

BLAKE WOLFE | QMI AGENCY

TORONTO – Inside a brand-new medical clinic near the intersection of Yonge St. and Eglinton Ave., a patient walks up to the counter following his appointment.

An employee stands with him, offering advice on the man’s new medication.

“Be sure to grind it well before putting consuming it,” the staffer says. “You want it fluffy like dryer lint. Fluffy is your friend when it comes to vaporizers.”

The patient thanks him for the advice and heads out the door.

It’s a normal exchange at the Cannabinoid Medical Clinic — CMClinic for short — Toronto’s first referral-only medical marijuana clinic.

It was a busy first week for executive director Dr. Danial Schecter and his staff after officially opening the clinic’s doors on July 14 and seeing dozens of the approximately 700 patients on the wait list. Talk of additional clinics in Canada is already taking place, Schecter says.

The clinic opened in the wake of new federal regulations regarding medical marijuana use. The rules, which came into effect on April 1, require that patients procure their stash from an approved supplier with a doctor’s prescription.

Schecter, who learned of marijuana’s medical effects while studying at the University of Montreal, set up the Toronto clinic after successfully using the plant to treat several patients at his former practice near Georgian Bay.

“I had a patient who suffered from anxiety so badly that he literally flapped when he walked into my office,” recalled Schecter, adding that the man self-medicated with alcohol and was afraid to consume marijuana for fear of returning to prison. “I saw his treatment as a success, and when the new regulations were announced, it was an opportunity to help many more people.”

Despite criticism from some doctors and health organizations about the lack of evidence for marijuana’s medical benefits, Schecter said he hopes to change that perception by contributing to the emerging field through his work at the clinic. He explained that in his experience, family doctors fall into three categories:

The 10% who are firmly opposed to the medical use of weed, another 10% who are open to the concept but cautious, and the 80% who are willing to prescribe it as a last resort for patients who have tried everything else.

“This is something that’s talked about for maybe five or 10 minutes in medical school,” Schecter mused. “The research done here will allow us to make a solid contribution to a novel field of medicine. I’m trying to educate the skeptical physicians and help that 80% (willing to prescribe marijuana).”

While other marijuana clinics have recently sprung up in Toronto, Schecter is quick to point out that CMClinic is referral-only and is covered through OHIP, similar to other medical specialists that a patient may be referred to by their family doctor.

Clinic spokesman Bridget Best said the facility operates more as a referral and educational centre for doctors and patients who may need assistance in learning about the various forms that cannabis can take as well as the myriad consumption methods.

Schecter said that as opposed to the typical recreational user who may consume mass quantities of weed due to tolerance of the drug, his patients often manage their pain by using less than a gram per day.

While patients are free to consume marijuana in whichever way they choose, the clinic sells vaporizers (which create marijuana vapour instead of smoke) as opposed to typical head shop fare like glass pipes and bongs.

No marijuana is stored on site, Best said.

Pursuing a medication more often associated with recreational and illicit consumption is often a last resort for most of the clinic’s patients — many of whom hail from various points across the GTA and southern Ontario, while others still have inquired from as far away as Germany and Panama.

Schecter, who said that he tries to avoid prescribing pot to anyone under 25 due to the inconclusive effects of the drug on the growing brain, deals predominantly with patients in “chronic pain,” ranging from those suffering with the lingering effects of accidents and chemotherapy to those requiring palliative care.

Travelling to the clinic from Bowmanville, patient Bob Landry recalled the 2011 traffic accident that left him with lingering pain and headaches. While Landry said that he has successfully used marijuana to treat his condition after traditional prescription drugs proved either ineffective or unthinkable, he sought out the clinic to help with proper dosages.

“I tried normal painkillers first, then my doctor offered me Oxycontin — I refused,” Landry said, explaining that his cousin had died from the controversial drug. “I believe this is the solution. I prefer to acquire it legally and, this way, I know what I’m getting.

“I hope to one day return to my normal activities.”

Source: http://www.sunnewsnetwork.ca/sunnews/canada/archives/2014/07/20140720-162102.html

Tags: , , ,
Posted in Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Toronto opens first referral-only medical marijuana clinic

Medical Marijuana on BTV Headlining Abattis, Lexaria, Endexx, & Affinor Growers

Posted by AGORACOM-JC at 2:20 PM on Thursday, July 17th, 2014

Vancouver, British Columbia–(July 17, 2014) – BTV-Business Television goes on location to bring investors expert analyst commentary and stories on emerging companies for their portfolio.

Watch our investment show on TV and online to gain market insight: Full Episode

Please visit:
http://www.b-tv.com/the-btv-show/episodes.html?id=230

On BNN and FOX Business News Network on Sun July 20, 2014 – on National TV, BTV-Business Television showcases the following companies:

Abattis Bioceuticals Corp. (OTCQX: ATTBF) (CSE: ATT) – capitalizing on the growing trend toward marijuana legalization in the US and Canada by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and marketing support to licensed growers. Video(http://www.b-tv.com/features/watch-now.html?id=602)

Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) – BTV visits this early adapter that’s already received municipal approval in Ontario for their first medical marijuana production facility. Video (http://www.b-tv.com/features/watch-now.html?id=603)

Endexx Corp. (OTCPINK: EDXC) – supporting the cannabis industry through technology services and compliancy platforms. Video (http://www.b-tv.com/features/watch-now.html?id=604)

Affinor Growers (CSE: AFI) – automating the food production systems in Canada and the US and endeavoring to get into the medical marijuana market. Video (http://www.b-tv.com/features/watch-now.html?id=605)

And commentary from:

Alan Brochstein – Analyst, 420Investor on what to check in cannabis companies: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_1.wmv). Cannabis trends: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_2.wmv). Technology in marijuana space: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_3.wmv). Marijuana stocks: video (http://www.b-tv.com/i/videos/AlanBrochsteinEp297_4.wmv).

Horst Hueniken – President, Dundee Agricultural Corp. on medical marijuana sector: video (http://www.b-tv.com/i/videos/HorstHuenikenEp297_1.wmv). Technology in cannabis space: video (http://www.b-tv.com/i/videos/HorstHuenikenEp297_2.wmv).

BTV, a half-hour weekly business news program, profiles emerging companies across Canada and the USA to bring investors information for their portfolio. With Host Taylor Thoen, BTV features companies at their location, interviews the company’s key executives and features their business.

BTV BROADCAST TIMES:
CANADA: BNN – Sunday, July 20 @ 9:30am & 8:00pm EST
Bell Express Vu – Sunday, Jun 20 @ 9:30am & 8:00pm EST

U.S. National: Fox Business News – Sunday, July 20 @ 5:00pm EST
America One – Saturday, July 19 @ 10am EST
Biz Television Network – Thurs. Jul 24 @ 10:00pm & 1:00am EST and Sun Jul 27 @ 12:30pm, 9:00pm & 12:00am EST

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp. | Comments Off on Medical Marijuana on BTV Headlining Abattis, Lexaria, Endexx, & Affinor Growers

Lexaria Intends to Complete a $5,100,000 Financing

Posted by AGORACOM-JC at 8:35 AM on Thursday, July 17th, 2014

Kelowna, British Columbia–(July 17, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered convertible debenture financing, to raise gross proceeds of up to US $5,100,000. The debenture will have a term with a maturity date that is one year from the offering close.

The convertible debenture will pay 2.5% per annum simple interest, quarterly in arrears. Under certain conditions, the debenture is either refundable or, at the investor’s option may be converted into either a five-year note bearing 11% per annum simple interest or into equity of the Company at the price of US$0.30.

In connection with the convertible debenture, the Company may pay broker commissions of up to 2% cash and 8% in broker warrants exercisable at US$0.50 for a period of 12 months following closing of the Offering. Certain directors, officers and insiders of the Company may participate in the Private Placement.

Any securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day. Proceeds from the convertible debenture, under certain conditions, are to be used for corporate development in the Medical Marijuana business and G&A. The convertible debenture is subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Manager: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the proposed financing of up to $5,100,000 will be successful.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO US WIRE SERVICES. FOR CANADIAN DISTRIBUTION ONLY.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Intends to Complete a $5,100,000 Financing

Municipal Approval for Lexaria-Enertopia Joint Venture in Burlington, Ontario

Posted by AGORACOM-JC at 7:34 AM on Monday, July 14th, 2014

Kelowna, British Columbia–(Newsfile Corp. – July 14, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria“) is pleased to announce that the production of Medical Marihuana in compliance with Health Canada MMPR regulations has received final Municipal zoning approval for the Lexaria/Enertopia joint venture. Previously announced only as being located in the Greater Toronto Area, now that Municipal approval has been obtained Lexaria is happy to announce the facility location as Burlington, Ontario.

The evaluation procedures of the City of Burlington were followed, including presentations made to city officials and opportunities for public feedback and input. Lexaria is pleased that the City of Burlington showed community leadership and vision in implementing a thoughtful series of rules for the cultivation of medical marijuana in accordance with Federal Health Canada regulations.

“Approval by the City of Burlington for a medical marijuana production facility is an important step in the journey towards our goal of obtaining a license under Health Canada’s MMPR program and becoming a leader in the industry,” said Chris Bunka, CEO of Lexaria Corp.

Now that the City of Burlington has passed a bylaw permitting medical marijuana production facilities, Lexaria expects that the joint venture license application to Health Canada will be submitted soon.

The bylaw approving the medical marijuana facility zoning was passed by Burlington officials on June 9th, and the period of time when appeals were allowed to be heard expired on July 9, 2014. Notice of passing of the Bylaw was provided on July 10, and at this time the bylaw is in existence.

The Lexaria/Enertopia joint venture, as previously reported, is for a building of approx 30,000 sq ft for first phase design, with a right of first refusal obtained for approx another 45,000 sq ft. Since the original announcement of this facility on April 10, 2014, a great deal of progress has been made regarding the state of the art design concepts expected to be implemented.

The joint venture has engaged David Hyde & Associates for security design and implementation. David Hyde & Associates is a full service security management and business risk consulting and training practice that offers independent, high quality advisory services underpinned by real-world security and risk management experience. David Hyde & Associates, widely acknowledged as one of Canada’s leading security experts, has previously been a security consultant to another existing company that has already received their license under the MMPR program.

The joint venture has also engaged KNY Architects Inc, a design and planning firm headquartered in Burlington that has been in business for over 55 years. They have completed hundreds of projects across Canada, USA, and the Ukraine.

A total of 880,000 restricted common shares will be issued to a number of persons in accordance with previously entered agreements, upon reaching the municipal approval milestone. The securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Separately, Lexaria has accepted the resignation of Chris Hornung as Assistant Operations Manager.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp. Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Inquiries: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that any municipality where proposed facilities are located will retain its approval for a medical marijuana production facility. The Company is not currently growing or selling medical marijuana.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Municipal Approval for Lexaria-Enertopia Joint Venture in Burlington, Ontario

Next Gen Announces Private Placement

Posted by AGORACOM-JC at 8:36 AM on Thursday, July 3rd, 2014

Vancouver, British Columbia, Canada / July 3, 2014 – Next Gen Metals Inc., (“Next Gen”, the “Company”) (CSE: N; OTC: NXTTF; Frankfurt: M5BN) is pleased to announce a non-brokered private placement of up to 3,000,000 units for gross proceeds of up to $300,000.

Each Unit (“Unit”) at a price of $0.10 per unit will consist of one common share (a “Common Share”) and one-half of one, non-transferrable share purchase warrant (a “Warrant”). Each full Warrant entitles the holder to purchase one Common Share at a price of $0.20 per share during the first year, $0.30 per share during the second year and $0.40 per share during the third year.

The proceeds from the private placement will be used for acquisitions, investments and working capital to advance the company’s initiatives in the Medical Marijuana, Industrial Hemp and Alternative Medicine industries as well as advancing the company’s GreenRush Financial Conference business. The private placement and any finder’s fees payable are subject to regulatory approval. Any securities issued pursuant to the private placement shall be subject to a four month and a day hold period commencing on the closing date.

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangements to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries. For further information on the company, visit our website at www.nextgenmetalsinc.com .

On March 20, 2014 Next Gen Metals announced that it had established its first wholly owned subsidiary, a Conference Division that intends to host Canada’s first conferences focused on business to business opportunities, the investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Financial Conferences’ vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

If you are interested in being a speaker, exhibitor or sponsor for future Financial Conferences please submit your indication of specific interest as soon as possible to the GreenRush Financial Conference team as the available spaces are fill up quickly.

On May 6, 2014 NextGen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories vision is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

NextGen’s Management’s intention is to invest in a basket of companies within these growing industries. The company’s business model continues to generate new business plans and project submittals 24/7

In light of Next Gen’s vision, Management is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, Brokerage and Consultancy Solutions, Public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

NextGen’s Corporate Structure

 


Click Image To View Full Size

For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.
About GreenRush Financial Conferences

Click Image To View Full Size

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (Public Company, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

We would also like to invite the participants, attendees, keynote speakers, industry and investment experts all to attend to our next conferences which are slated for the Seattle, WA-Fall 2014 with additional conferences in Calgary, Edmonton, Montreal, other US cities and Europe in 2014-2015

 

Investors and other interested parties are invited to attend and learn about investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine business sector


Click Image To View Full Size

About GreenRush Analytical Laboratories Inc.:

GreenRush Laboratories (GAL) is NextGen’s fully owned subsidiary providing Analytical Analysis for medical-grade cannabis products. GAL will seek to become a certified Analytical Laboratory under the new Marijuana for Medical Purposes Regulations (MMPR) and will establish analytical laboratories equipped to provide product analysis and micro propagation and other professional services to Licensed Producers, distributers, caregivers and Industrial Hemp farmers.

Our goal is to provide analytical testing to the cannabis industry to ensure the health and safety of consumers and to maximize the quality of our client’s products.

For further information on GreenRush Analytical Laboratories Inc. please visit us at http://www.greenrushanalyticallabs.com/


Click Image To View Full Size

 

GreenRush Business Brokerage (GBB)

GreenRush Business Brokerage (GBB) is a business brokerage and advisory and consultancy business unit of NextGen (CSE: N, OTC Pink: NXTTF, FSE: M5BN), GBB is headquartered in Vancouver, British Columbia with satellite offices in Toronto and Rockport, Ontario, and Maui county, Hawaii, USA. GreenRush Business Brokerage unit serves as an intermediary between buyers and sellers of small to medium-size businesses across the Medical Marijuana, Industrial Hemp and Alternative medicine industries.

For further information on this Private Placement and general Investor Relations Inquiries please contact us by phone or email at [email protected].

Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The CSE has neither reviewed nor approved the contents of this News Release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on Next Gen Announces Private Placement

Media Advisory – Toronto GreenRush Financial Conference

Posted by AGORACOM-JC at 9:13 AM on Wednesday, June 25th, 2014

TORONTO, June 25, 2014 /CNW/ –

WHAT: A First for Toronto! GreenRush Financial Investment Conferences
WHEN: June 26, 2014 7:30 AM– 6 PM
WHERE: Metro Toronto Convention Centre North Constitution Hall

Please visit www.greenrushfinancialconferences.com to view Speakers And Exhibitors attending the conference

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

GreenRush Financial Conferences is 100% owned by Next Gen Metals Inc. (Next Gen, CSE:N)


ATTENTION: MEDIA / FINANCIAL ADVISORS

“THE BIRTH OF A NEW INDUSTRY!”

CORPORATE PRESENTATION
MEDIA CONFERENCE / FINANCIAL ADVISOR BREAKFAST

 

WHAT The Purpose of this corporate presentation is to advise the Financial Industry and Media about GreenRush Financial Investment Conferences.
WHEN June 26, 2014, 7:30 – 8:15 AM
WHERE METRO TORONTO CONVENTION CENTRE NORTH CONSTITUTION HALL 106
WHO Harry Barr
President & CEO of Next Gen, GreenRush Financial Conferences
Khurram Malik, Co-Head of Equity Research, Jacob Securities
Rob Cook, Senior Vice-President Canadian Securities Exchange
This presentation is hosted by Next Gen and its wholly owned subsidiary, GreenRush Financial Conferences, The Canadian Securities Exchange and Jacob Securities Inc.
RSVP Send an email to [email protected] to RSVP

The Hosts of the Press Conference share a similar vision: specifically they believe in the need to provide a forum for Education, Venture Capital, Investment, Finance, Business to Business Opportunities, as well as to act as facilitators for these emerging industries.

About Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi‐billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.
For further information on the company, visit our website at www.nextgenmetalsinc.com

SOURCE Next Gen Metals Inc.

Call Taylor at 604.808.7250, email [email protected] CNW Group 2014

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Next Gen | Comments Off on Media Advisory – Toronto GreenRush Financial Conference

Next Gen’s GreenRush Financial Conference announces Impressive Lineup of Speaker

Posted by AGORACOM-JC at 5:24 PM on Tuesday, June 24th, 2014

 

Vancouver, British Columbia, Canada / June 24th, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) and its wholly owned subsidiary GreenRush Financial Conferences have organized for its first conference in Toronto, Ontario, on June 16th, an impressive slate of speakers representing all aspects of the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

 


Click Image To View Full Size

The Conference keynote speaker is Mr. Josh Stanley, of Charlotte’s web fame. He will be speaking at 12:15 p.m. on Thursday, June 26.

Josh Stanley is a leading medical cannabis entrepreneur and advocate working to advance the medical cannabis industry in the United States and throughout the world. Josh has worked in the medical cannabis industry for over seven years and was one of the first individuals to open a medical marijuana dispensary in Denver, Colorado. He started Colorado’s first true political action committee and 501c4, the Medical Marijuana Industry Group, which he co-chaired.

In 2010, Josh assisted in the drafting of House Bill 1284, the first bill of its kind to further define and establish Colorado’s medicinal cannabis state regulatory structure through the Colorado Department of Revenue. The following year he assisting in drafting House Bill 1043 and was responsible for writing the research and development portion of the bill. Josh sat on the rules and regulations board of the Colorado Department of Revenue’s Medical Marijuana Enforcement Division as well as the rules and regulations board for research and development.

Josh worked with National Geographic Channel on a groundbreaking television series called American Weed that chronicled his family’s mission to keep medical marijuana legal in Colorado and tracked his observational research studies and patient successes with medical cannabis.

Josh is credited with creating the idea to breed a non psychoactive strain of the cannabis plant with low Tetrahydrocannabinol (THC) and high Cannabidiol (CBD) content which became known as “Charlotte’s Web.” This specialized sativa varietal of medical cannabis has shown promising results in alleviating symptoms of intractable pediatric epilepsy as well as a variety of other illnesses and disease states. Josh’s effort to help children restore their lives with high-CBD cannabis extracts made international headlines in 2013 and was prominently featured on Sanjay Gupta’s highly acclaimed CNN documentary special WEED, and just recently in March of 2014 was followed by the sequel, WEED 2.

Josh had the honor to perform a TEDx Talk in Boulder, Colorado that allows viewers to understand, in less than 19 minutes, the true healing powers of medicinal hemp, (high CBD strains).

A much sought after speaker, Josh has the ability to sift through the propaganda and fear encompassing the medical marijuana industry and delivers a compassionate appeal to end cannabis prohibition. Josh has recently been active in international arenas as he seeks to foster the advocacy for medicinal rights to cannabis on the global stage. .

Full list of Conference Speakers: For a complete list of speakers and their profiles which shows their diversity and areas of expertise including scheduled presentation times, please visit www.greenrushfinancialconferences.com and click on the Agenda page.

Management welcomes everyone who has an interest whether personal or for business to attend the GreenRush Conference and listen to all of the speakers who will provide an insight into a wide range of topics within their respected fields of expertise.
About GreenRush Financial Conferences
GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.
The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

About Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries. For further information on the company, visit our website at www.nextgenmetalsinc.com

On behalf of the Board of Directors

“Harry Barr”
Harry Barr, President and CEO
FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Next Gen | Comments Off on Next Gen’s GreenRush Financial Conference announces Impressive Lineup of Speaker

« Older Entries
Newer Entries »